TRICUSPID REGURGITATION (TR)
Clinical trials for TRICUSPID REGURGITATION (TR) explained in plain language.
Never miss a new study
Get alerted when new TRICUSPID REGURGITATION (TR) trials appear
Sign up with your email to follow new studies for TRICUSPID REGURGITATION (TR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New heart valve device aims to ease severe leakage
Disease control Not yet recruitingThis study tests a new device called LuX-Valve Plus for people with severe tricuspid regurgitation, a condition where a heart valve leaks badly. About 680 adults will get either the new device or a standard one, and researchers will check safety and how well it works. The goal is…
Matched conditions: TRICUSPID REGURGITATION (TR)
Phase: NA • Sponsor: Jenscare Innovation Inc. • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New heart valve replacement offers hope for patients with severe leaky valve
Disease control Not yet recruitingThis study tests a new device called the TRiCares Topaz to replace a leaky heart valve (tricuspid regurgitation) in people with severe symptoms. About 831 adults who are not helped enough by standard medicines will get the valve. The goal is to see if it is safe and improves qual…
Matched conditions: TRICUSPID REGURGITATION (TR)
Phase: NA • Sponsor: TRiCares • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New catheter aims to better predict risk before heart valve repair
Knowledge-focused Not yet recruitingThis study tests a special catheter that measures how well the right side of the heart is working in people with severe tricuspid regurgitation (a leaky heart valve). The goal is to see if this tool can help doctors better understand patient risk before valve repair. The study wi…
Matched conditions: TRICUSPID REGURGITATION (TR)
Sponsor: Feldman Cardiology, PLLC • Aim: Knowledge-focused
Last updated May 26, 2026 08:01 UTC
-
Valve repair may unlock higher doses of heart meds
Knowledge-focused Not yet recruitingThis observational study will enroll 50 adults with severe tricuspid regurgitation (a leaky heart valve) and reduced heart function. Researchers want to see if repairing the valve with the PASCAL Precision System allows patients to safely increase their heart failure medications …
Matched conditions: TRICUSPID REGURGITATION (TR)
Sponsor: Ceric Sàrl • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC